Berton, G., Bewersdorf, J. P., Gilhodes, J., Iat, A., Soua, A., DeAngelo, D. J., Boussi, L., Shallis, R. M., Žučenka, A., Bystrom, R. P., Ling, K., Aguirre, L. E., Stone, R. M., Luskin, M. R., Garcia, J. S., Winer, E. S., Chen, E. C., Wadleigh, M., Mendez, L., Podoltsev, N., Tauveron-Jalenques, U., Lanino, L., Stein, E., Zeidan, A. M., Forcade, E., Cluzeau, T., Dumas, P.-Y., Heiblig, M., Devillier, R., Shimony, S., Goldberg, A. D., Stahl, M. and Garciaz, S. (2020) “Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.300202.